Category Press Releases

Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Advancing Data Center AI Infrastructure” – emphasizes the strategic leap in Qualcomm’s architecture for enterprise-scale AI Qualcomm Technologies, Inc. has announced the launch of its next-generation AI inference-optimized solutions for data centers: the Qualcomm® AI200 and Qualcomm® AI250 chip-based accelerator…

Read MoreQualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference
Chemetall

IMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025

IMCD Showcases Greener, Smarter, and Patient-Centric Pharmaceutical Innovations at CPHI Frankfurt 2025 a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced its participation at CPHI Frankfurt 2025, taking place from 28–30 October. At this…

Read MoreIMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025

Arrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis

Arrowhead Pharmaceuticals Announces Completion of Global Licensing and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a leading biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics, announced today that its previously disclosed global licensing and collaboration agreement…

Read MoreArrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis
Aptar Pharma’s Unidose Device Powers FDA Approval

Aptar Pharma’s Unidose Device Powers FDA Approval of Enbumyst™, First Intranasal Diuretic

Aptar Pharma, a global leader in drug delivery and active material science solutions, announced that its Unidose Liquid System (UDS) has been selected as the delivery technology for Enbumyst™ (Bumetanide Nasal Spray) 0.5 mg, recently approved by the U.S. Food…

Read MoreAptar Pharma’s Unidose Device Powers FDA Approval of Enbumyst™, First Intranasal Diuretic